Bernard Coulie has been appointed as the CEO of Pliant Therapeutics.
4 reports, 2 independent
Updated Aug 1
Gone quiet
- Reports
- 4
- Developments
- 2
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bernard Coulie has been appointed as the CEO of Pliant Therapeutics.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Bernard Coulie is the CEO of Pliant Therapeutics.1 source
- Pliant received news of an unfavorable risk-benefit profile from its trial data.
Keep exploring
The entities involved
-
Bernard Coulie
Belgian academic and historian
Nothing else this week.
-
Pliant (United States)
company in South San Francisco, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- manilatimes.net
- GlobeNewswirePliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results BEACON-IPF close out activities continue Previously announced workforce and operational realignment lar
- Unknown outlet
- Unknown outlet